These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 20673799

  • 1. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.
    van Horssen J, Drexhage JA, Flor T, Gerritsen W, van der Valk P, de Vries HE.
    Free Radic Biol Med; 2010 Nov 01; 49(8):1283-9. PubMed ID: 20673799
    [Abstract] [Full Text] [Related]

  • 2. SETD6 is a negative regulator of oxidative stress response.
    Chen A, Feldman M, Vershinin Z, Levy D.
    Biochim Biophys Acta; 2016 Feb 01; 1859(2):420-7. PubMed ID: 26780326
    [Abstract] [Full Text] [Related]

  • 3. DJ-1 plays an important role in caffeic acid-mediated protection of the gastrointestinal mucosa against ketoprofen-induced oxidative damage.
    Cheng YT, Ho CY, Jhang JJ, Lu CC, Yen GC.
    J Nutr Biochem; 2014 Oct 01; 25(10):1045-57. PubMed ID: 25037998
    [Abstract] [Full Text] [Related]

  • 4. Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer.
    Merikallio H, Pääkkö P, Kinnula VL, Harju T, Soini Y.
    Hum Pathol; 2012 Apr 01; 43(4):577-84. PubMed ID: 21943684
    [Abstract] [Full Text] [Related]

  • 5. 15-Deoxy-Δ12,14-prostaglandin J₂ modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes.
    Lee E, Yin Z, Sidoryk-Węgrzynowicz M, Jiang H, Aschner M.
    Free Radic Biol Med; 2012 Mar 15; 52(6):1067-74. PubMed ID: 22245093
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy.
    Bitar MS, Liu C, Ziaei A, Chen Y, Schmedt T, Jurkunas UV.
    Invest Ophthalmol Vis Sci; 2012 Aug 24; 53(9):5806-13. PubMed ID: 22836768
    [Abstract] [Full Text] [Related]

  • 11. Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
    Nijland PG, Witte ME, van het Hof B, van der Pol S, Bauer J, Lassmann H, van der Valk P, de Vries HE, van Horssen J.
    Acta Neuropathol Commun; 2014 Dec 10; 2():170. PubMed ID: 25492529
    [Abstract] [Full Text] [Related]

  • 12. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.
    Hulshof S, Montagne L, De Groot CJ, Van Der Valk P.
    Glia; 2002 Apr 01; 38(1):24-35. PubMed ID: 11921201
    [Abstract] [Full Text] [Related]

  • 13. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J, van der Pol S, Nijland P, Amor S, Perron H.
    Mult Scler Relat Disord; 2016 Jul 01; 8():11-8. PubMed ID: 27456869
    [Abstract] [Full Text] [Related]

  • 14. Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
    Draheim T, Liessem A, Scheld M, Wilms F, Weißflog M, Denecke B, Kensler TW, Zendedel A, Beyer C, Kipp M, Wruck CJ, Fragoulis A, Clarner T.
    Glia; 2016 Dec 01; 64(12):2219-2230. PubMed ID: 27641725
    [Abstract] [Full Text] [Related]

  • 15. Experimental encephalomyelitis induces changes in DJ-1: implications for oxidative stress in multiple sclerosis.
    Lev N, Ickowicz D, Barhum Y, Blondheim N, Melamed E, Offen D.
    Antioxid Redox Signal; 2006 Dec 01; 8(11-12):1987-95. PubMed ID: 17034344
    [Abstract] [Full Text] [Related]

  • 16. Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1.
    Cuevas S, Yang Y, Konkalmatt P, Asico LD, Feranil J, Jones J, Villar VA, Armando I, Jose PA.
    Hypertension; 2015 Jun 01; 65(6):1251-7. PubMed ID: 25895590
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology.
    Schreibelt G, van Horssen J, van Rossum S, Dijkstra CD, Drukarch B, de Vries HE.
    Brain Res Rev; 2007 Dec 01; 56(2):322-30. PubMed ID: 17761296
    [Abstract] [Full Text] [Related]

  • 19. DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway.
    Im JY, Lee KW, Woo JM, Junn E, Mouradian MM.
    Hum Mol Genet; 2012 Jul 01; 21(13):3013-24. PubMed ID: 22492997
    [Abstract] [Full Text] [Related]

  • 20. Radical changes in multiple sclerosis pathogenesis.
    van Horssen J, Witte ME, Schreibelt G, de Vries HE.
    Biochim Biophys Acta; 2011 Feb 01; 1812(2):141-50. PubMed ID: 20600869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.